Fair Market Value and Price-Setting in ILPA Continuation Fund Transactions

Conflict of Interest: The GP on Both Sides of the Transaction

A GP proposing a continuation fund transaction occupies a position of structural conflict that no amount of process can eliminate. As the investment manager of the existing fund, the GP is a fiduciary to the existing fund's LPs. Its duty runs to those LPs and requires it to seek fair value for the assets being transferred out of the fund. As the investment manager of the proposed continuation vehicle, the GP has a direct economic interest in acquiring those same assets at the lowest price consistent with obtaining LP and LPAC support for the transaction. These two roles are irreconcilable in a single agent.

The conflict is sharpened by the GP's carried interest economics. If the GP's existing fund carry is crystallized at a higher transfer price, the GP benefits through accelerated carry realization. If a lower transfer price is set, the continuation vehicle investors - including the GP's own rollover economics - stand to benefit from subsequent appreciation. Depending on the GP's carry position in each vehicle, the incentive can point in either direction, and neither direction is automatically aligned with what is fair to the selling fund's LPs.

The GP also controls information that no other party possesses with equivalent depth. Its knowledge of the portfolio company's business, financial condition, strategic options, and exit timeline is more current and more granular than any information available to secondary buyers conducting arm's-length due diligence through a data room. This information asymmetry is inherent to the structure and cannot be fully resolved through data room disclosure alone.

The fiduciary tension is managed, not resolved. The mechanisms used to manage it - competitive auction processes, independent valuations, fairness opinions, LPAC consent, and documentation of the price discovery process - are designed to demonstrate that the GP acted in the selling fund's LPs' interests despite the conflict. Whether those mechanisms were actually adequate is the question that SEC examiners, LP litigation counsel, and institutional LP consultants will ask if the transaction is ever challenged.

GPs who approach the conflict as a disclosure-and-consent box to be checked rather than a genuine governance process create exposure. A fairness opinion obtained from a conflicted adviser, an LPAC process where members lacked independent counsel, or an auction conducted without a genuine competitive dynamic does not insulate the GP from liability merely because it formally satisfied each procedural step. The substance of each process element matters as much as its formal completion.

ILPA April 2023 GP-Led Secondary Fund Transactions Guidance: Structural Recommendations

ILPA published its GP-Led Secondary Fund Transactions Guidance in April 2023 following several years of rapid growth in continuation fund transaction volume and increasing LP concern about process quality and conflicts management. The guidance is organized around four primary areas: transaction process, valuation and pricing, LP and LPAC engagement, and fee and expense transparency. Each area contains specific recommendations that represent ILPA's position on what constitutes adequate practice.

On transaction process, ILPA recommends that GPs use a structured, competitive process managed by an independent process manager to establish the transfer price. The guidance specifically discourages bilateral price negotiations with a single secondary buyer as the sole pricing mechanism, particularly where that buyer is also receiving a stapled primary commitment. ILPA's position is that a competitive process, even a narrow one with a small number of participants, produces a more defensible transfer price than a bilateral negotiation because it introduces external market validation of the pricing.

On valuation and pricing, ILPA recommends both an independent third-party valuation and a fairness opinion as distinct procedural elements that serve different purposes. The independent valuation establishes a methodology-supported range for the assets' fair market value. The fairness opinion confirms that the specific transaction price is fair to the selling fund's LPs from a financial point of view. ILPA notes that these two functions are analytically distinct and should not be performed by the same provider in circumstances where doing so would create an appearance of circular validation.

On LP and LPAC engagement, the guidance recommends that the LPAC be engaged early in the process, before transaction terms are finalized, so that LPAC input can influence the process design rather than merely review a completed structure. ILPA recommends providing the LPAC with access to independent legal counsel and with a disclosure package that includes the fairness opinion, the independent valuation, and a description of the GP's economic interests in the transaction.

On fee and expense transparency, ILPA recommends full disclosure of all fees paid to all advisers in connection with the transaction, including process manager fees, fairness opinion fees, placement agent fees, and legal fees, with a clear statement of which fees are borne by the fund versus the GP. The guidance notes that LP-borne expenses for continuation fund transactions should be capped at levels that reflect the actual cost of services benefiting LPs and should not include fees that primarily benefit the GP's interest in completing the transaction.

Price Discovery via Competitive Auction: Process Manager Role, Data Room, and Management Presentations

A competitive auction process for a continuation fund transaction is structured to generate multiple independent bids from secondary buyers, creating a market-based reference point for the transfer price. The process is typically managed by an independent secondary adviser or investment bank retained as process manager. The process manager's role is distinct from the GP's role: the process manager coordinates the buyer outreach, manages the data room access, schedules management presentations, collects and evaluates bids, and advises the GP on bid quality and comparability. A process manager who is retained by the GP and paid a transaction fee conditioned on closing is not fully independent, and ILPA guidance calls for transparency about the process manager's fee structure.

The buyer universe in a continuation fund process is typically limited to institutional secondary buyers with the capacity and appetite to underwrite the specific assets. A broad auction with a large number of participants is less common because data room access and management presentations require the GP to disclose detailed non-public information about the portfolio company, and each additional participant increases the risk of information leakage. Most GP-led processes involve between three and ten secondary buyers at the initial indicative bid stage, with a subset advancing to the final bid stage after completing detailed diligence.

The data room should contain the same quality and depth of information that the GP would provide to a buyer in a control sale of the portfolio company. Financial statements, operating metrics, cap table, key customer and supplier contracts, management reports, and legal diligence materials are standard data room contents. A data room that contains only summary materials or that excludes information that secondary buyers routinely require undermines the credibility of the pricing process and exposes the GP to claims that the auction was designed to produce a specific outcome rather than genuine market discovery.

Management presentations are typically conducted for buyers who have submitted satisfactory indicative bids and are advancing to the final round. The presentation allows buyers to ask the portfolio company management team direct questions about the business, its strategy, and its competitive position. The GP must balance the goal of maximizing buyer confidence - which supports higher bids - against the portfolio company's sensitivity about disclosing forward-looking plans to parties who may not be the ultimate winning bidder.

The outcome of the competitive process is not automatically the highest bid received. The GP, in consultation with the LPAC, must evaluate bid quality, counterparty reliability, the terms of any stapled commitment attached to a bid, and the closing certainty offered by each finalist. A higher headline price with significant conditionality may be less valuable to selling LPs than a slightly lower price from a buyer with a track record of clean closings in similar transactions.

Independent Third-Party Valuation: Qualified Provider, Methodology Disclosure, and Range vs. Point Estimate

An independent third-party valuation is a formal assessment of the fair market value of the assets to be transferred, conducted by a valuation firm that is not affiliated with the GP, the continuation vehicle, or the lead secondary buyer. The purpose of the independent valuation is to establish a methodology-supported range of fair market value against which the transaction price can be evaluated. It is not a certification that the transaction price is fair; that function belongs to the fairness opinion. The independent valuation provides the analytical foundation on which other elements of the price discovery process rest.

The selection of the valuation provider should reflect genuine independence. A valuation firm that has an ongoing advisory relationship with the GP, that receives material fees from the GP in connection with other mandates, or that was retained at the GP's direction without LPAC input may lack the independence necessary to make the valuation meaningful. ILPA recommends that the LPAC have input into the selection of the independent valuation provider in significant transactions.

Methodology disclosure is a required component of a credible independent valuation. The valuation report should identify the methodologies applied, the weighting assigned to each, the key assumptions underlying each methodology, and the sensitivity of the valuation range to changes in those assumptions. Common methodologies for private equity portfolio company valuations include discounted cash flow analysis, comparable public company trading multiples, comparable transaction multiples, and asset-based approaches for asset-heavy businesses. The report should explain why each methodology was given the weight it received and how the methodologies were reconciled to produce a range.

A range estimate, rather than a point estimate, is more consistent with the inherent uncertainty of private company valuation. A valuation that produces a single precise number implies false precision and is harder to defend than one that acknowledges the range within which fair market value reasonably falls. The transaction price should fall within the range or, if it falls outside the range, the deviation should be explained by reference to transaction-specific factors such as control premium, liquidity discount, or unique buyer synergies.

The independent valuation should be completed before the transaction price is finalized and delivered to the LPAC as part of the disclosure package. A valuation conducted after the transaction price has been agreed, or that is conducted by a provider who knows the agreed price before beginning its analysis, is analytically compromised and will not satisfy the independence standard that ILPA guidance and SEC examination expectations require.

Fairness Opinion from Investment Bank: Scope Limitations, Fiduciary Out Reliance, and Limitations of Reliance

A fairness opinion in a continuation fund transaction is a written opinion from a qualified investment bank or financial adviser stating that the transfer price is fair, from a financial point of view, to the limited partners of the selling fund. The opinion is addressed to the GP as manager of the fund, or to the LPAC, depending on how the engagement is structured. It is not a guarantee that the price is optimal or that no better price could have been achieved; it is a professional judgment that the price falls within a reasonable range of fairness.

The scope of a fairness opinion in a continuation fund context is narrower than might be assumed. The opinion provider typically relies on information provided by the GP and does not conduct an independent audit of the portfolio company's financial condition. The opinion is based on market conditions as of the date it is rendered and does not address whether the price will prove to have been fair in hindsight. It does not opine on the structure of the transaction, the tax consequences, or the adequacy of the process by which the price was determined.

The fiduciary out reliance issue arises because the LPAC and existing LPs may treat the fairness opinion as the primary basis for their decision to approve the conflict waiver and accept the transaction price. This reliance is not unreasonable, but it should be informed reliance. The LPAC and its independent counsel should review the scope of the opinion, the assumptions on which it relies, the qualifications and conflicts of the opinion provider, and the limitations set out in the opinion itself before treating it as a sufficient basis for approval.

The limitations of reliance section in a fairness opinion typically states that the opinion is delivered for the benefit of the addressee and may not be relied upon by any other person. This limitation is significant in the continuation fund context because secondary buyers, incoming CV investors, and rolling LPs may each want to rely on the opinion as part of their own evaluation. The opinion provider will typically not extend reliance rights without conducting its own assessment of the party seeking to rely, and attempting to obtain reliance rights from a conflicted provider creates additional questions about independence.

The independence of the opinion provider is a recurring examination focus. An investment bank that is also acting as placement agent for the continuation vehicle, that has an existing banking relationship with the portfolio company, or that has received substantial fees from the GP within the prior 12 months may have economic incentives that affect the objectivity of its opinion. These relationships should be disclosed to the LPAC before it relies on the opinion, and in significant transactions the LPAC may consider engaging a second, genuinely independent opinion provider.

Lead Secondary Buyer Bid as Reference Point: Stapled Commitment Influence and Information Asymmetry

In many GP-led continuation fund transactions, the GP negotiates with a lead secondary buyer before launching a formal auction process. The lead buyer commits to acquire the continuation vehicle interests at a specified price and on specified terms, and the GP then uses that price as a reference point for the LP election process and for any additional secondary buyers brought into the transaction. The lead buyer's bid is the anchor for the transaction economics.

The lead buyer occupies a privileged position in the price discovery process. It typically conducts more extensive due diligence than other potential buyers, has direct management access, and may have an existing relationship with the GP from prior fund investments. This informational advantage, combined with the commercial relationship between the GP and the lead buyer, creates conditions in which the lead buyer's price is not necessarily the result of arms-length negotiation. The lead buyer may be willing to pay a premium to secure the relationship benefits of the transaction, or it may use its negotiating leverage to extract a discount relative to what a competitive process would produce.

Stapled primary commitments compound this dynamic. A lead buyer who receives a primary commitment to the GP's next fund as part of the transaction package has a blended economic interest that makes the continuation vehicle pricing analytically inseparable from the primary commitment terms. A buyer who pays above market for the continuation vehicle assets in exchange for primary access is not providing a clean market reference for the continuation vehicle price. The GP must disclose the existence and material terms of any staple to the LPAC and explain why the continuation vehicle price is a credible market reference notwithstanding the stapled economics.

Information asymmetry between the GP and secondary buyers is a structural feature of the process that cannot be eliminated but can be partially mitigated. Buyers who have not previously invested in the GP's funds, who are unfamiliar with the portfolio company's market, or who receive data room materials that are less complete than what the GP knows about the business are at a disadvantage in assessing fair value. The quality and completeness of the data room is therefore not merely a commercial issue but a governance issue: it affects the credibility of the resulting bids as market pricing evidence.

Where the lead buyer's bid is the only bid or is treated as the definitive market reference without a genuine competitive process, the GP's conflict management framework is at its most exposed. A single-buyer transaction price, without independent valuation support and a robust fairness opinion, is the structure most likely to draw LPAC resistance and SEC examination scrutiny.

LPAC Consent Process: Disclosure Package, Independent Counsel, and Fee Reimbursement

The LPAC consent process is the primary governance mechanism through which the conflict of interest inherent in a GP-led continuation fund transaction is managed at the fund level. Most LPAs require affirmative LPAC consent before the GP can proceed with a transaction in which it has a conflict of interest. The consent is not a formality; it is a substantive approval that requires the LPAC to evaluate the transaction on the merits.

The disclosure package delivered to the LPAC should contain: a description of the proposed transaction and its structure; the identity of the lead secondary buyer and any other buyers participating in the transaction; the transfer price and the methodology used to determine it; the independent valuation report; the fairness opinion; a description of the GP's economic interests in the transaction, including carry treatment and any fees the GP or its affiliates will receive; a description of any stapled primary commitment and its material terms; and a description of the fees and expenses to be borne by the fund versus the GP. ILPA guidance calls for the disclosure package to be provided to the LPAC with sufficient lead time before the vote to allow meaningful review.

Independent legal counsel for the LPAC is now considered market standard in transactions of meaningful size. LPAC members are typically LP representatives who have fiduciary obligations to their own fund beneficiaries and who may not have the legal expertise to evaluate the transaction documents without assistance. LPAC counsel reviews the LPA provisions applicable to the conflict waiver, identifies any procedural deficiencies in the consent process, and advises LPAC members on their rights and obligations. The GP typically reimburses LPAC counsel fees as a fund expense.

LPAC members who have conflicts with respect to the specific transaction must recuse from the vote. The most common conflict requiring recusal is an LPAC member whose affiliated entity is participating as a lead secondary buyer or who has a financial interest in the continuation vehicle that differs from the interests of the selling fund's LPs. A vote taken by a conflicted LPAC, without adequate recusal, may not constitute valid consent to the waiver and may expose the GP to the argument that the conflict was not properly managed.

The timing of LPAC consent matters. The 45-day LP election period during which existing LPs choose between rolling over and taking cash should not begin until after the LPAC has approved the conflict waiver. Beginning the LP notice period before LPAC consent creates the risk that LPs receive notice and make elections based on a transaction that has not yet been approved, exposing the GP to liability if the transaction is later modified or unwound. The LPAC approval should be a prerequisite to the LP notice period, not a concurrent or subsequent step.

SEC Private Fund Adviser Rules: Conflicts and Disclosure Requirements, and Fifth Circuit Vacatur Implications

The SEC adopted the Private Fund Adviser Rules in August 2023, imposing on registered investment advisers a set of requirements that included mandatory quarterly statements, annual audited financial statements, fairness or valuation opinions for adviser-led secondary transactions, and restrictions on preferential treatment. The adviser-led secondary transaction provisions were directly applicable to continuation fund transactions, requiring GPs to obtain a fairness opinion from an independent opinion provider and to distribute that opinion to existing LPs before the LP election period.

The Fifth Circuit vacated the Private Fund Adviser Rules in their entirety in June 2024, holding that the SEC had exceeded its statutory authority under the Investment Advisers Act. The vacatur removed the mandatory compliance obligations that the rules imposed, including the fairness opinion requirement and the preferential treatment disclosure provisions. As a technical legal matter, registered investment advisers are no longer subject to these specific rule requirements.

The practical implications of the vacatur are more nuanced than a straightforward compliance calculation. SEC staff guidance and examination correspondence issued both before and after the vacatur indicate that the conflicts management principles underlying the vacated rules continue to inform examination expectations. The SEC's examination program evaluates whether advisers are managing and disclosing conflicts in a manner consistent with their fiduciary obligations, and the vacated rules were based on SEC staff's assessment of what adequate conflicts management requires. The standard has not changed substantively; the mandatory rule-based implementation mechanism has been removed.

GPs who contractually committed to LPs to comply with provisions of the Private Fund Adviser Rules - whether through side letter obligations, LPA amendments, or direct representations in offering documents - should review those commitments separately. The vacatur does not extinguish contractual obligations; it removes the regulatory overlay. A GP who represented to LPs that it would comply with the adviser-led secondary transaction provisions of the rules remains bound by that representation even though the underlying rule is no longer in effect.

The disclosure obligations under Section 206 of the Advisers Act, which prohibit fraudulent, deceptive, or manipulative practices, remain in full effect. A GP who fails to disclose material conflicts, presents misleading information to LPs about the transfer price or the GP's economic interests, or selectively omits information that would affect LP elections is exposed to enforcement action under Section 206 regardless of whether any specific rule provision requires the disclosure.

Discount to NAV Analysis: Secondary Market Pricing Benchmarks and Bid-Ask Spreads

Reported NAV is the starting point for secondary market pricing analysis, but it is rarely the ending point. The GP-reported NAV for a portfolio company reflects the GP's valuation methodology and assumptions as of the most recent quarterly valuation date, which may be months prior to the continuation fund transaction date. Secondary buyers apply their own discount or premium to reported NAV based on their independent underwriting of the asset's value and their return requirements.

Discounts to NAV in GP-led continuation fund transactions have historically been narrower than discounts observed in LP secondary sales of diversified fund portfolios, for a structural reason: the GP-led process involves assets that the GP has specifically identified as having compelling forward value, which creates an information signal that secondary buyers treat as meaningful. A GP willing to stake its reputation and continue managing an asset in a new vehicle is implicitly signaling confidence in the asset's value. This signal narrows the information gap between GP and buyer and supports tighter pricing.

Bid-ask spread dynamics affect the pricing outcome in continuation fund transactions in ways that differ from control sale processes. Secondary buyers are not acquiring operating control of the portfolio company and cannot independently verify all assumptions underlying the GP's valuation. They apply liquidity discounts and execution risk adjustments that reflect the secondary market structure rather than the intrinsic value of the underlying business. These secondary-specific adjustments can produce transfer prices that are below what the same asset might achieve in a controlled auction to a strategic or financial buyer.

Secondary market pricing benchmarks published by secondary advisers and academic researchers provide a frame of reference but should be used cautiously. Aggregate pricing statistics reflect a wide range of assets, vintages, sectors, and market conditions. The relevant comparison for a specific continuation fund transaction is not the aggregate secondary market but the pricing achieved in comparable single-asset or concentrated portfolio GP-led transactions involving similar asset types and quality.

Existing LPs evaluating a transaction priced at a discount to NAV must assess whether the discount reflects genuine market pricing for the asset in the secondary context or whether a better process would have yielded a narrower discount. The LPAC's evaluation of this question benefits from access to the independent valuation range and from the process manager's assessment of bid quality relative to other transactions in the secondary market.

Premium to NAV Scenarios: Trophy Assets, Scarcity Value, and Strategic Buyer Bids

Continuation fund transactions are not invariably priced at a discount to reported NAV. In circumstances where the asset has characteristics that command premium pricing from secondary buyers, the transfer price may meet or exceed NAV. Understanding when premium scenarios arise, and what drives them, is important for LPs evaluating whether a proposed transaction price is credible.

Trophy asset dynamics arise when a portfolio company occupies a market leadership position that gives it scarcity value in the secondary market. Leading businesses in defensible categories that are rarely available as secondary investments attract buyers who are willing to pay a premium to gain exposure to an asset they could not otherwise access. The scarcity premium reflects the limited supply of comparable investment opportunities rather than a fundamental valuation difference, and it is real: buyers compete for access, and competition drives pricing above what a standard DCF-based valuation would suggest.

Scarcity value is related to but distinct from trophy asset pricing. A business in a niche market with a small number of institutional-quality comparable companies may command premium pricing in the secondary market because secondary buyers who want sector exposure have few alternatives. This pricing premium is a function of supply and demand in the secondary market rather than the intrinsic value of the specific asset, and it can persist even for assets that secondary buyers would price at a discount in a deeper market.

Strategic buyer bids occasionally appear in continuation fund processes when a strategic acquirer is invited to participate alongside secondary buyers, or when a strategic buyer independently approaches the GP about acquiring the portfolio company outright. A strategic bid that values synergies not captured in the secondary pricing framework may significantly exceed secondary market pricing. The GP's decision about whether to solicit or accept strategic bids alongside secondary bids is a process design choice with significant pricing implications.

For the LPAC and existing LPs, a transaction priced at a premium to reported NAV presents a different set of analytical questions than a discount transaction. The premium validates the GP's valuation methodology and suggests that the secondary market competition was genuine. The primary question for LPs is whether the reported NAV was itself conservative - meaning the true fair market value exceeds both NAV and the transaction price - or whether the premium reflects transaction-specific dynamics, including a stapled primary commitment that inflated the lead buyer's willingness to pay.

Transaction Fees and Expenses Allocation: GP vs. Fund, Cap on LP-Borne Expenses

Fee and expense allocation in a continuation fund transaction is a specific conflict of interest because the GP controls which fees are charged to the fund and which are absorbed by the GP. Overcharging the fund for transaction costs that primarily benefit the GP is a form of self-dealing. ILPA guidance calls for complete transparency about all fees and expenses and for clear principles governing which costs are fund obligations versus GP obligations.

The general principle is that costs incurred for the benefit of the selling fund's LPs are fund expenses, and costs incurred for the GP's own benefit or in connection with the GP's interest in the continuation vehicle are GP expenses. Applying this principle requires analysis of each expense category. Process manager fees may be entirely fund expenses if the process manager's role is to maximize the transfer price for the selling fund's LPs, or may be split if the process manager is also assisting the GP in raising the continuation vehicle.

Fairness opinion fees are generally fund expenses because the opinion is obtained for the benefit of the LPAC and existing LPs. Independent LPAC counsel fees are fund expenses because the LPAC acts on behalf of the fund's LPs. Legal fees for the transaction documents may be split depending on whether specific documents primarily protect LP interests or the GP's interests. Carried interest crystallization costs, including tax advice and accounting fees associated with the GP's carry realization, are GP expenses.

A cap on LP-borne expenses is a mechanism for limiting the total amount of transaction costs charged to the fund, regardless of actual costs incurred. LPA provisions and side letters negotiated by institutional LPs sometimes include expense caps for GP-led secondary transactions. These caps may be stated as an absolute dollar amount or as a percentage of the transaction value. GPs should respect contractual expense caps and should not structure fee arrangements to circumvent them.

The disclosure obligation for transaction fees extends to all fees paid in connection with the transaction, including fees paid by the portfolio company to its own advisers if those fees are ultimately borne by the fund through reduction in enterprise value, and fees paid to placement agents for raising the continuation vehicle if those fees are charged back to the fund. A complete fee disclosure that allows the LPAC to understand the total cost of the transaction to existing LPs is a baseline governance requirement.

Documentation and Record-Keeping for Conflicts Defense: Committee Minutes, Process Memos, and Audit Trail

The documentation standard for a GP-led continuation fund transaction is the standard for any fiduciary action taken under a conflict of interest: the record must be sufficient to demonstrate, to a person reviewing it without prior knowledge of the transaction, that the GP acted in the selling fund's LPs' best interests despite the conflict. This is not a standard that can be satisfied retroactively by reconstructed records or summary memoranda prepared after the fact.

Investment committee minutes documenting the decision to pursue the continuation fund transaction should reflect the committee's evaluation of the conflict, the process it approved to manage the conflict, and the basis for its conclusion that the process was sufficient. Minutes that simply note approval of the transaction without documenting the conflict analysis do not satisfy the governance record requirement and will not be viewed favorably by SEC examiners reviewing the transaction.

Process memos should document each stage of the price discovery process: the decision to engage a process manager, the criteria used to select the process manager, the buyer outreach process, the number of buyers contacted and the number who received data room access, the bids received and the basis for selecting the winning bid, and the relationship between the winning bid and the independent valuation range and fairness opinion. These memos should be prepared contemporaneously with each process milestone, not compiled after the transaction closes.

LPAC meeting minutes and consent documentation should include: the agenda and materials provided to the LPAC, the names of members present and any members who recused, the substance of the LPAC's discussion, the vote outcome, and any conditions or qualifications attached to the consent. LPAC counsel should be identified in the minutes, and any written advice provided by LPAC counsel should be retained as part of the transaction record.

The valuation and fairness opinion documentation should include the final reports in their complete form, all correspondence with the opinion providers, and any supplemental analyses or updates prepared in connection with price negotiations. Draft reports that were prepared but not finalized, and communications between the GP and opinion providers during the analytical process, are part of the record. A record that contains only the final opinions but omits the deliberative process leading to those opinions is incomplete and will not satisfy the documentation standard in an adversarial review.

Frequently Asked Questions

Related Resources

Fair market value in a continuation fund transaction is not a number that emerges automatically from market forces. It is a conclusion supported by a process, and the quality of that process determines whether the conclusion is defensible. A competitive auction, an independent valuation, a fairness opinion from an unaffiliated adviser, an informed LPAC consent, complete fee disclosure, and a contemporaneous documentation record are not optional enhancements. They are the framework within which the GP's fiduciary obligation to the selling fund's LPs is either honored or abandoned.

The Fifth Circuit's vacatur of the SEC Private Fund Adviser Rules removed mandatory rule compliance but did not change the underlying analysis. The conflicts inherent in GP-led continuation fund transactions are structural. Managing them requires substantive attention to process quality, not merely formal satisfaction of procedural requirements. The transactions that withstand scrutiny are the ones where the GP treated each governance mechanism as a genuine protection for its LPs, not as a series of boxes to be checked on the way to closing.